Platinum-Based Regimens Are Active in Advanced Pediatric-Type Rhabdomyosarcoma in Adults and Depending on HMGB1 Expression
Rhabdomyosarcoma (RMS) in adults is a rare and aggressive disease, which lacks standard therapies for relapsed or advanced disease. This retrospective study aimed to describe the activity of BOMP-EPI (bleomycin, vincristine, methotrexate and cisplatin alternating with etoposide, cisplatin and ifosfa...
Main Authors: | Nadia Hindi, Jaime Carrillo-García, Elena Blanco-Alcaina, Marta Renshaw, Pablo Luna, José Durán, Natalia Jiménez, Pilar Sancho, Rafael Ramos, David S. Moura, Javier Martín-Broto |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/1/856 |
Similar Items
-
Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells
by: Kazutaka Ouchi, et al.
Published: (2020-05-01) -
HMGB family proteins: Potential biomarkers and mechanistic factors in cardiovascular diseases
by: Xialei Zheng, et al.
Published: (2023-09-01) -
Disulfide and Fully Reduced HMGB1 Induce Different Macrophage Polarization and Migration Patterns
by: Henna Salo, et al.
Published: (2021-05-01) -
Emerging Role of High-Mobility Group Box 1 (HMGB1) in Liver Diseases
by: Ruochan Chen, et al.
Published: (2013-11-01) -
Targeting Inflammation Driven by HMGB1 in Bacterial Keratitis—A Review
by: Linda D. Hazlett, et al.
Published: (2021-09-01)